Related Experiment Video
Updated: Apr 27, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Bacteriophage-derived CHAP domain protein, P128, kills Staphylococcus cells by cleaving interpeptide cross-bridge of
Sudarson Sundarrajan1, Junjappa Raghupatil1, Aradhana Vipra1
1GangaGen Biotechnologies Pvt. Ltd, No. 12 5th cross, Raghavendra layout, Tumkur road, Yeshwantpur, Bangalore 560022, India.
Abstract:
P128 is an anti-staphylococcal protein consisting of the Staphylococcus aureus phage-K-derived tail-associated muralytic enzyme (TAME) catalytic domain (Lys16) fused with the cell-wall-binding SH3b domain of lysostaphin. In order to understand the mechanism of action and emergence of resistance to P128, we isolated mutants of Staphylococcus spp., including meticillin-resistant Staphylococcus aureus (MRSA), resistant to P128. In addition to P128, the mutants also showed resistance to Lys16, the catalytic domain of P128. The mutants showed loss of fitness as shown by reduced rate of growth in vitro. One of the mutants tested was found to show reduced virulence in animal models of S. aureus septicaemia suggesting loss of fitness in vivo as well. Analysis of the antibiotic sensitivity pattern showed that the mutants derived from MRSA strains had become sensitive to meticillin and other β-lactams. Interestingly, the mutant cells were resistant to the lytic action of phage K, although the phage was able to adsorb to these cells. Sequencing of the femA gene of three P128-resistant mutants showed either a truncation or deletion in femA, suggesting that improper cross-bridge formation in S. aureus could be causing resistance to P128. Using glutathione S-transferase (GST) fusion peptides as substrates it was found that both P128 and Lys16 were capable of cleaving a pentaglycine sequence, suggesting that P128 might be killing S. aureus by cleaving the pentaglycine cross-bridge of peptidoglycan. Moreover, peptides corresponding to the reported cross-bridge of Staphylococcus haemolyticus (GGSGG, AGSGG), which were not cleaved by lysostaphin, were cleaved efficiently by P128. This was also reflected in high sensitivity of S. haemolyticus to P128. This showed that in spite of sharing a common mechanism of action with lysostaphin, P128 has unique properties, which allow it to act on certain lysostaphin-resistant Staphylococcus strains.
Insights
P128 protein resistance in Staphylococcus mutants involves femA gene mutations, impacting peptidoglycan cross-bridge cleavage. These resistant mutants exhibit reduced fitness and altered antibiotic sensitivity.
Area of Science:
- Microbiology
- Biochemistry
- Molecular Biology
Background:
- P128 is a novel anti-staphylococcal protein engineered from phage-K and lysostaphin components.
- Understanding resistance mechanisms is crucial for developing effective anti-staphylococcal therapies.
Purpose of the Study:
- To investigate the mechanism of action and resistance emergence against P128 in Staphylococcus species.
- To characterize P128-resistant mutants and identify genetic alterations responsible for resistance.
Main Methods:
- Isolation and characterization of P128-resistant Staphylococcus mutants.
- Analysis of mutant fitness, virulence, and antibiotic sensitivity.
- Sequencing of the femA gene and investigation of peptidoglycan cross-bridge cleavage.
Main Results:
- P128-resistant mutants exhibited reduced growth and virulence, with some MRSA mutants regaining sensitivity to beta-lactams.
- Mutations in the femA gene were identified in resistant strains, suggesting impaired peptidoglycan cross-bridge formation.
- P128 effectively cleaved pentaglycine cross-bridges and demonstrated activity against lysostaphin-resistant strains, including Staphylococcus haemolyticus.
Conclusions:
- Resistance to P128 in Staphylococcus spp. is associated with femA mutations and compromised peptidoglycan cross-bridge integrity.
- P128 exhibits a unique mechanism of action, targeting pentaglycine cross-bridges and showing efficacy against certain lysostaphin-resistant staphylococci.
Related Concept Videos
DNA Bacteriophages
Inhibitors of Gram-positive Cell Wall Synthesis
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Viral Replication: Lytic Cycle
Regulation of Bacterial Virulence
Gene Regulation in Microbial Communities: Quorum Sensing

